No advantage of dexamethasone over prednisolone for the outcome of standard- and intermediate-risk childhood acute lymphoblastic leukemia in the Tokyo Children's Cancer Study Group L95-14 protocol

Author

IGARASHI, Shunji; MANABE, Atsushi; SUGITA, Ken-Ichi; SUGITA, Kanji; MAEDA, Miho; YABE, Hiromasa; KINOSHITA, Akitoshi; KANEKO, Takasht; HAYASHI, Yasuhide; IKUTA, Kouichiro; HANADA, Ryohji; TSUCHIDA, Masahiro; OHARA, Akira; KUMAGAI, Masaaki; SAITO, Tomohiro; OKIMOTO, Yuri; KAMIJO, Takehiko; ISOYAMA, Keiichi; KAJIWARA, Michiko; SOTOMATSU, Manabu
Department of Hematology-Oncology, Chiba Children's Hospital, Chiba, Japan
Department of Hematology-Oncology, Gunma Children's Medical Center, Seta, Japan
Department of Hematology-Oncology, Saitama Children's Medical Center, Iwatsuki, Japan
Department of Hematology-Oncology, Tokyo Metropolitan Klyose Children's Hospital, Kiyose, Japan
Department of Pediatrics, Dokkyo University School of Medicine, Utsunomiya, Japan
Department of Pediatrics, Ibaraki Children's Hospital, Mito, Japan
Department of Pediatrics, Japanese Red Cross Maebashi Hospital, Maebashi, Japan
Department of Pediatrics, Japanese Red Cross Nanta Hospital, Nanta, Japan
Department of Pediatrics, Showa University, School of Medicine, Fujigaoka Hospital, Department of Pediatrics, Yokohama City University, School of Medicine, Yokohama, Japan
Department of Pediatrics, St Marianna University School of Medicine, Kawasaki, Japan
Department of Pediatrics, Tokai University, School of Medicine, Isehara, Japan
Department of Pediatrics, Tokyo Medical and Dental University, School of Medicine, Department of Pediatrics, Nippon Medical School, Tokyo, Japan
Department of Pediatrics, University of Shinshu, School of Medicine, Matsumoto, Japan
Department of Pediatrics, Yamanashi University, School of Medicine, Kofu, Japan
Tokyo Children's Cancer Study Group, Departments of Hematology and Epidemiology, National Center for Child Health and Development, Department of Pediatrics, St Luke's International Hospital, First Department of Pediatrics, Toho University, Tokyo, Japan

Source

Journal of clinical oncology. 2005, Vol 23, Num 27, pp 6489-6498, 10 p ; ref : 19 ref

ISSN

0732-183X

Scientific domain

Medical oncology

Publisher

Lippincott Williams & Wilkins, Baltimore, MD

Publication country

United States

Document type

Article

Language

English

Keyword (fr)

Aigu Anticancéreux Cancérologie Dexaméthasone Enfant Epidémiologie Facteur risque Leucémie aiguë Leucémie lymphoblastique Norme Prednisolone Pronostic Tumeur maligne Corticostéroïde Homme Hormone stéroïde Hormone surrénalienne Hémopathie maligne Lymphoprolifératif syndrome

Keyword (en)

Acute Antineoplastic agent Cancerology Dexamethasone Child Epidemiology Risk factor Acute leukemia Acute lymphocytic leukemia Standards Prednisolone Prognosis Malignant tumor Corticosteroid Human Steroid hormone Adrenal hormone Malignant hemopathy Lymphoproliferative syndrome

Keyword (es)

Agudo Anticanceroso Cancerología Dexametasona Niño Epidemiología Factor riesgo Leucemia aguda Leucemia linfoblástica Norma Prednisolona Pronóstico Tumor maligno Corticoesteroide Hombre Hormona esteroide Hormona suprarrenal Hemopatía maligna Linfoproliferativo síndrome

Classification

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis

Discipline

Blood diseases Tumours

Origin

Inist-CNRS

Database

PASCAL

INIST identifier

17232906

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS